These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 25716178)

  • 1. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients.
    Xi Z; Zhang M; Bruni AC; Maletta RG; Colao R; Fratta P; Polke JM; Sweeney MG; Mudanohwo E; Nacmias B; Sorbi S; Tartaglia MC; Rainero I; Rubino E; Pinessi L; Galimberti D; Surace EI; McGoldrick P; McKeever P; Moreno D; Sato C; Liang Y; Keith J; Zinman L; Robertson J; Rogaeva E
    Acta Neuropathol; 2015 May; 129(5):715-27. PubMed ID: 25716178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.
    Xi Z; Rainero I; Rubino E; Pinessi L; Bruni AC; Maletta RG; Nacmias B; Sorbi S; Galimberti D; Surace EI; Zheng Y; Moreno D; Sato C; Liang Y; Zhou Y; Robertson J; Zinman L; Tartaglia MC; St George-Hyslop P; Rogaeva E
    Hum Mol Genet; 2014 Nov; 23(21):5630-7. PubMed ID: 24908669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
    Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
    Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion.
    Xi Z; Zinman L; Moreno D; Schymick J; Liang Y; Sato C; Zheng Y; Ghani M; Dib S; Keith J; Robertson J; Rogaeva E
    Am J Hum Genet; 2013 Jun; 92(6):981-9. PubMed ID: 23731538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jump from pre-mutation to pathologic expansion in C9orf72.
    Xi Z; van Blitterswijk M; Zhang M; McGoldrick P; McLean JR; Yunusova Y; Knock E; Moreno D; Sato C; McKeever PM; Schneider R; Keith J; Petrescu N; Fraser P; Tartaglia MC; Baker MC; Graff-Radford NR; Boylan KB; Dickson DW; Mackenzie IR; Rademakers R; Robertson J; Zinman L; Rogaeva E
    Am J Hum Genet; 2015 Jun; 96(6):962-70. PubMed ID: 26004200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between repeat number in C9orf72 and phenotypic variability in Turkish patients with frontotemporal lobar degeneration.
    Erzurumluoglu E; Cilingir O; Ozbabalik Adapinar BD; Bilgic B; Kocagil S; Ozen H; Durak Aras B; Yenilmez C; Artan S
    Neurobiol Aging; 2019 Apr; 76():216.e1-216.e7. PubMed ID: 30685122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.
    Cooper-Knock J; Shaw PJ; Kirby J
    Acta Neuropathol; 2014 Mar; 127(3):333-45. PubMed ID: 24493408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
    Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
    Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases.
    Porta S; Kwong LK; Trojanowski JQ; Lee VM
    J Neuropathol Exp Neurol; 2015 Apr; 74(4):380-7. PubMed ID: 25756586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
    Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
    Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Šket P; Pohleven J; Kovanda A; Štalekar M; Župunski V; Zalar M; Plavec J; Rogelj B
    Neurobiol Aging; 2015 Feb; 36(2):1091-6. PubMed ID: 25442110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and genetic characterization of two dizygotic twins with C9orf72 expansion.
    Conforti FL; Tortelli R; Morello G; Capozzo R; Barulli MR; Cavallaro S; Logroscino G
    Neurobiol Aging; 2018 Sep; 69():293.e1-293.e8. PubMed ID: 29866399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.
    Stepto A; Gallo JM; Shaw CE; Hirth F
    Acta Neuropathol; 2014 Mar; 127(3):377-89. PubMed ID: 24366528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients.
    Belzil VV; Bauer PO; Gendron TF; Murray ME; Dickson D; Petrucelli L
    Brain Res; 2014 Oct; 1584():15-21. PubMed ID: 24530272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Vatovec S; Kovanda A; Rogelj B
    Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
    Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier.
    Russ J; Liu EY; Wu K; Neal D; Suh E; Irwin DJ; McMillan CT; Harms MB; Cairns NJ; Wood EM; Xie SX; Elman L; McCluskey L; Grossman M; Van Deerlin VM; Lee EB
    Acta Neuropathol; 2015 Jan; 129(1):39-52. PubMed ID: 25388784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.
    Cruts M; Gijselinck I; Van Langenhove T; van der Zee J; Van Broeckhoven C
    Trends Neurosci; 2013 Aug; 36(8):450-9. PubMed ID: 23746459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
    Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; DeCarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JB; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; van der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VM; Van Deerlin V; Chen-Plotkin AS
    Acta Neuropathol; 2014 Mar; 127(3):407-18. PubMed ID: 24442578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.